Qube Research & Technologies (QRT)
RANI icon

Qube Research & Technologies (QRT)’s Rani Therapeutics RANI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-47,508
Closed -$34.9K – 3958
2026
Q1 		$34.9K Sell
47,508
-100,718
-68% -$129K ﹤0.01% 3228
2025
Q4 		$200K Buy
+148,226
New +$224K ﹤0.01% 3060
2024
Q3 		– Sell
-3
Closed -$12 – 3961
2024
Q2 		$12 Hold
3
– – ﹤0.01% 3604
2024
Q1 		$9 Hold
3
– – ﹤0.01% 4300
2023
Q4 		$10 Hold
3
– – ﹤0.01% 4168
2023
Q3 		$7 Buy
+3
New +$11 ﹤0.01% 3951
2023
Q2 		– Sell
-19,907
Closed -$103K – 2893
2023
Q1 		$103K Buy
+19,907
New +$120K ﹤0.01% 2118

Other funds holding RANI

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LP
Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RANI Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Rani Therapeutics (RANI) in Q2 2026, closing a stake of 47,508 shares — an estimated $34.9K sold.

Qube Research & Technologies (QRT) first reported a position in RANI in Q1 2023 and held it in 7 quarters. The position peaked at $200K in Q4 2025. 68 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Rani Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 47,508 Rani Therapeutics shares in Q2 2026, an estimated $34.9K.
  • Qube Research & Technologies (QRT) first reported a position in Rani Therapeutics in Q1 2023 and held it in 7 quarters.
  • Qube Research & Technologies (QRT)'s Rani Therapeutics position peaked at $200K in Q4 2025.
  • 68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.